Stock price performance of Interpace Diagnostics Group, Inc. is analyzed for various periods using several stock trading signals. In this case, The stock price has rallied 170.55% in the past 12 Weeks , but analyzing the 6 month charts for the stock , the price continues to stay positive and keep the rally at 10.84% . Looking at the past 52 week period, the stock price is up at 21.54% . Relative price strength is a important factor used by wealth management firms while investing in stocks because the indicator compares the stock performance with the overall market. The relative price strength of Interpace Diagnostics Group, Inc. has a positive value of 57.14 compared to overall market. For the current week, the company shares have a recommendation consensus of Buy. The stock has recorded a 20-day Moving Average of 21.25% and the 50-Day Moving Average is 13.65%.The 200 Day SMA reached 26.92%
Interpace Diagnostics Group, Inc. is having a Relative Strength Index of 43.28 which indicates the stock is not yet over sold or over bought based on the technical indicators. Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) has tumbled 27.36% during the past week and has dropped 51.16% in the last 4 week period. The stocks are negative as compared to the S&P 500 for the past week with a loss of 27.44%. Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) has underperformed the index by 51.59% in the last 4 weeks. Investors should watch out for further signals and trade with caution.
Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) stock ended Friday session in the red zone in a volatile trading. The stock closed down 1.16 points or 26.85% at $3.16 with 1,483,465 shares getting traded. Post opening the session at $3.15, the shares hit an intraday low of $3.09 and an intraday high of $3.3 and the price was in this range throughout the day. The company has a market cap of $8.9 million and the number of outstanding shares has been calculated to be 2,806,252 shares. The 52-week high of Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) is $19.8 and the 52-week low is $0.7.
Interpace Diagnostics Group, Inc. provides molecular diagnostic tests. The companys test consists of ThyGenX Thyroid Oncogene Panel (R), Thyroid miRNA(TM) and PancraGen(TM). Interpace Diagnostics Group Inc, formerly known as PDI Inc., is headquartered in Parsippany, New Jersey.